Episode Details

198 - Healthcare's Consolidation Crunch Meets AI's Mega Buildout—And New Regulatory Crossroads

Episode 198 Published 3 months, 2 weeks ago

Description

Vic and Marcus discuss uncertainty around Federal Reserve interest rate policy, continued strength in AI infrastructure and semiconductor markets, and major venture funding across biotech and value-based care. They examine proposed NIH research policy changes, the impact of Medicaid enrollment reductions and rising ACA premiums, Medicare Advantage legal disputes, healthcare bankruptcies, labor strikes, and Ascension's acquisition of Williamson Health. They also cover major pharmaceutical acquisitions, expanding access to peptides, advances in brain-computer interfaces, the challenges of integrating wearable data into clinical care, blockchain's growing role in banking, China's evolving AI strategy, Apple's lawsuit against OpenAI, and the rapid expansion of AI data center infrastructure.

Story Lineup

1 — In This Economy

00:58 - Story 1: Fed Chair Warsh Signals Divided Views on Inflation Path Amid AI Buildout

2:12 - Story 2: SK Hynix Lands $26B Nasdaq IPO, World's Largest Non-US Chip Offering [CNBC]

2 — VC Deal Review

4:00 - Story 1: Leo Cancer Care Secures $65M Series D for Upright Radiotherapy System Ahead of IPO [Fierce Biotech]

4:42 - Story 2: MeiraGTx Secures $400M Growth Capital for Gene Therapy Commercialization [Fierce Biotech]

5:57 - Story 3: Pearl Health Raises $110M to Scale Value-Based Care Infrastructure for Medicare [MedCity News]

3 — Policy

7:04 - Story 1: Trump OMB Grant Overhaul Draws 99K Comments From Scientists Warning of NIH Politicization [The New York Times]

9:06 - Story 2: Biotech Revenue Projections Darkened by Trump Tax Bill's Medicaid Enrollment Impact [Fierce Biotech]

4 — Health Payors